Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

MYSTERIOUS: 15 | Mind Blowing Facts

Scientists surprised to find human body makes its own Ozempic version

Study finds body’s ‘built-in backup plan’ for diabetes-controlling hormone production

The Independent UK

Doctors Sound Alarm Over Concerning Cause Behind Rise In Giant Baby Births

"Whose baby is this? He came out of me?"

Bored Panda

Could This New Drug Be The Safer Way To Fight Obesity?

On Friday, Skye Bioscience, Inc. (NASDAQ:SKYE) announced the presentation of results from the Phase 1b study of nimacimab in subjects with metabolic-associated steatotic liver disease (MASLD) at the European Association for the Study of Diabetes (EASD) Annual Meeting.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Daily arthritis pill could slow progression of diabetes, trial finds

The drug is already used to treat several autoimmune diseases, including rheumatoid arthritis, ulcerative colitis, and alopecia

The Independent UK

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device.

Benzinga

New AI tool predicts risk of more than 1,000 medical conditions a decade in advance

The model can accurately predict conditions such as diabetes and cancer, and is less reliable for issues such as infectious diseases and mental health disorders.

Euronews

New type of jab helps to maintain weight loss

Experts have developed a new drug which helps tackle the underlying causes of obesity.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Could This Eli Lilly Oral Pill Be Key To Significant Weight Loss?

Eli Lilly and Co (NYSE:LLY) on Tuesday shared detailed results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of oral orforglipron in adults with obesity, or overweight with a weight-related medical problem, and without diabetes.

Benzinga

Serious mental illness often brings rapid weight gain – but support is missing

Being diagnosed with a serious mental illness like schizophrenia or bipolar disorder often brings an overlooked challenge: rapid and sustained weight gain. This side-effect can raise the risk of diabetes, heart disease and early death – widening an already stark life expectancy gap.

The Conversation

We studied over 160,000 pregnancies to show how your postcode affects you and your baby

Where a woman lives can shape her health during pregnancy as much as her own medical history, our new study suggests.

The Conversation

Study recommends ‘planetary diet’ to cut diabetes risk and emissions

Researchers say dietary changes are crucial part of effort to tackle global heating

The Independent UK

Combining vaping and smoking may raise risk of diabetes and prediabetes, study finds

Users of e-cigarettes have a 7 per cent higher risk of developing prediabetes compared with non-smokers, according to a new US study.

Euronews

Weight loss drug semaglutide shown to be safe and potentialy more effective at higher dose – new findings

A higher dose of the weight loss drug semaglutide (better known by its brand name Wegovy) may help people lose up to 25% of their body weight – without the risk of severe side-effects. These findings are based on the results of two recently published clinical trials.

The Conversation

Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact

On Monday, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) approved an update to Novo Nordisk A/S‘ (NYSE:NVO) Rybelsus (oral semaglutide) label to reflect the cardiovascular benefits seen in the SOUL trial.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Euronews

Weight loss drugs like Ozempic work well for kids and teens, study finds. But should kids take them?

The Independent UK

Obese children as young as six could benefit from weight-loss jabs

About a third of children leaving primary school are overweight or living with obesity in England

International Business Times UK

'F* You': 10 Photos of Kathy Bates and Her Shocking Clapback to Critics After 100-Pound Weight Loss

Kathy Bates, the 77-year-old Oscar-winning actress, lost 100 pounds over several years, addressing critics who credited Ozempic alone. Motivated by a diabetes diagnosis and family health history, she transformed her lifestyle, gaining confidence, energy and renewed focus on her career.

Euronews

Half of people on weight loss drugs quit within one year, expert says it’s ‘concerning’

People on weight loss medications such as Ozempic and Wegovy were more likely to stop taking the drugs if they were younger, lived in poorer areas, or were men.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Diabetes and dementia: The surprising link revealed by new research

The link between diabetes and dementia is becoming increasingly clear.

The Conversation

Ten ways diabetes and dementia are linked

The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect brain health and vice versa. Here are ten evidence-based insights into how the two conditions are related.

The Independent UK

Kathy Bates shares update on health difficulties after 100-pound weight loss

The actor began her weight loss journey after being diagnosed with diabetes in 2017

The Independent UK

Thousands at risk of invalidating travel insurance by using weight-loss jabs

About one-fifth of people incorrectly think weight-loss jabs are a lifestyle or cosmetic tool instead of a medical treatment

The Independent UK

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications

Euronews

Millions of people with diabetes do not know they have it. What are the signs?

People with diabetes were most likely to be diagnosed in high-income North America, and most likely to be treated in high-income Asia Pacific.

The Guardian - UK

Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition

Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly

1 … 14 15 16 17

People

Madeline Matty Matlock

19 stories

Ian Hughes

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Exeter

the Medical Research Future Fund

26 stories

SIPA

24 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.